CYTK:NASDAQ
Cytokinetics, Inc.
$73.62
arrow_downward
-0.66%(-0.49) 1D
$74.00
arrow_upward
+0.52% (+0.38)bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$73.23
High
$75.10
Low
$73.13
Mkt. cap
10.23B
Avg. vol.
1.89M
Volume
1.43M
52-wk high
$88.31
52-wk low
$47.22
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
Open
$73.23
High
$75.10
Low
$73.13
Mkt. cap
10.23B
Avg. vol.
1.89M
Volume
1.43M
52-wk high
$88.31
52-wk low
$47.22
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Investing.com
·
1 day ago
Cytokinetics at citigroup summit: hcm expansion drives growth hopes
GuruFocus
·
1 day ago
Cytokinetics (CYTK) Insider Sell: EVP Research & Development Fad
Simply Wall Street
·
2 days ago
Has Cytokinetics (CYTK) Become Fully Priced After Its Phase 3 Results?
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com